A Phase 1a, Randomised, Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and Tolerability of MEDI7836 in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 18 May 2017
At a glance
- Drugs MEDI 7836 (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors MedImmune
- 16 May 2016 Status changed from active, no longer recruiting to completed.
- 29 Dec 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 06 Aug 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.